Deniger Drew 4
4 · Alaunos Therapeutics, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Deniger Drew
VP, Research and Development
Transactions
- Award
Employee Stock Option (right to buy)
2023-03-15+125,000→ 125,000 totalExercise: $0.50Exp: 2033-03-14→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from March 15, 2023, with the first vesting occuring on June 15, 2023, subject to the Reporting Person's continued service through each such date.